DigniCap® scalp cooling system

The DigniCap® system is the first and only scalp cooling device to complete rigorous FDA clinical trials where seven out of 10 patients with early-stage breast cancer kept at least 50% of their hair.

Charleston Oncology has the DigniCap® System, which is FDA approved for women with breast cancer!

The machine works by cooling the scalp causing a reduced blood flow to that area so that less chemotherapy reaches the hair cells. Therefore this reduces chemotherapy-induced hair loss. Prior to this system, patients were required to use manual cold caps kept in freezers and dry ice. Patients would have to change them every 30 minutes to ensure the scalp would remain chilled. Now, you can sit comfortably in your chair with a fitted cap for the duration of your treatment.

This treatment is not covered by your insurance. Please call for pricing on this treatment and to set up an appointment with one of our physicians.

Visit www.dignicap.com for more information.

Choose your preferred location

West Ashley

North Charleston

Downtown

Summerville

Mt. Pleasant

Walterboro

Send UsA Message

    Melanoma Prevention and Awareness

    Melanoma Prevention and Awareness

    May is Skin Cancer Awareness Month. Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control. Watch the video to learn more about melanoma from Charleston Oncology’s Dr. Charles S. Holladay.

    read more
    Staying Aware for Breast Cancer Awareness Month

    Staying Aware for Breast Cancer Awareness Month

    Staying Aware for Breast Cancer Awareness monthCharleston Oncology is proud to sponsor Staying Aware for Breast Cancer Awareness month in conjunction with WCIV News Channel 4. We continue to partner with our community to ensure that every woman has the best chance of...

    read more
    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”

    read more
    Call Now Button